Latest News and Press Releases

WINNIPEG, MANITOBA--(Marketwired - June 25, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that on June 23, 2015, it issued 254,178 common shares of the...

WINNIPEG, MANITOBA--(Marketwired - June 25, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and...

WINNIPEG, MANITOBA--(Marketwired - May 13, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE), is a biotechnology company engaged in the development and commercialization of products that prevent and...

WINNIPEG, MANITOBA--(Marketwired - May 11, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...

WINNIPEG, MANITOBA--(Marketwired - March 26, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company developing and commercializing products that prevent and remove microbial...

WINNIPEG, MANITOBA--(Marketwired - March 24, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that on March 23, 2015, it issued 248,605 common shares of the Corporation...

WINNIPEG, MANITOBA--(Marketwired - Feb. 12, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company developing and commercializing products that prevent and remove microbial...

WINNIPEG, MANITOBA--(Marketwired - Jan. 12, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...

WINNIPEG, MANITOBA--(Marketwired - Dec. 23, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that on December 19, 2014, it issued 251,392 common shares of the...

WINNIPEG, MANITOBA--(Marketwired - Dec. 17, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech"), a biotechnology company engaged in the development of products...